EUCTR2005-001635-29-SE进行中(未招募)不适用
Kontrollerad utsättning av långvarig behandling med protonpumpshämmare.
Daniel Schmidt0 个研究点开始时间: 2005年7月12日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中(未招募)
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1. Minst 18 års ålder.
- •2. Minst tre månaders medicinering, kontinuerligt eller intermittent, med PPI där kontaktorsaken kan men ej behöver vara receptförnyelse, utan ha annan orsak, ej relaterad till nämnda medicinering.
- •3. Signerat informerat samtycke.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1. Graviditet.
- •2. Amning.
- •3. Gastroesofageal refluxsjukdom.
- •4. Ulcussjukdom.
- •5. Ulcusprofylax vid pågående medicinering med ASA/NSAID eller kortikosteroider.
- •6. Somatiska eller psykiska sjukdomar som omöjliggör deltagande i studien.
研究者
相似试验
已完成
不适用
Scheduled screening versus preventative treatment for the control of malaria in pregnancy in Malawi: a randomised controlled trialPregnancy and ChildbirthMalariaPACTR201103000280319iverpool School of Tropical Medicine1,656
进行中(未招募)
1 期
ot ApplicablePatient with neurological symptoms of Ataxia TelangiectasiaMedDRA version: 21.0Level: PTClassification code 10003594Term: Ataxia telangiectasiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-000338-36-DEEryDel S.p.A.104
Unknown
3 期
Open-label, Long-term, Extension Treatment using Intra-Erythrocyte Dexamethasone Sodium Phosphate in Patients with Ataxia Telangiectasia Who Participated in the IEDAT-02-2015 StudyCTRI/2019/02/017732EryDel SpA15
进行中(未招募)
1 期
ot ApplicableEUCTR2018-000338-36-BEEryDel S.p.A.51
进行中(未招募)
1 期
ot ApplicablePatient with neurological symptoms of Ataxia TelangiectasiaMedDRA version: 21.0Level: PTClassification code 10003594Term: Ataxia telangiectasiaSystem Organ Class: 10010331 - Congenital, familial and genetic disordersEUCTR2018-000338-36-NOEryDel S.p.A.104
